Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a San Francisco-based biotech startup that aims to make people live 10 years longer than what is considered a healthy human lifespan.
Altman already to give Retro Biosciences’ total seed capital is around $180 million. Now, the startup is raising a $1 billion Series A in which Altman is joining, and the Financial Times reports.
Retro Biosciences, which says it plans to start clinical trials of drugs against diseases such as Alzheimer’s, soon he taught by example and OpenAI to convert normal cells into stem cells.
CEO Joe Betts-LaCroix told the FT that he wants to move faster in identifying and developing drugs “in the 2020s.”
The startup joins other giant venture capital-backed ventures, including Altos Labs, which he started and $3 billion in 2022 with the support of Jeff Bezos, and Unity Biotechnology, to be helped and both Bezos and Peter Thiel.
